Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors — Stella

Home/Solid Tumor, Adult/A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Solid Tumor, Adult trials

A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

MD Anderson Cancer Center, Houston, Texas

Key details

Phase

Early testing / Safety & dosing

Sponsor

Crossignal Therapeutics, Inc.

Enrollment target

~78 participants

Started

September 2024

Primary completion

June 2027

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.